Immediate Impact
64 standout
Citing Papers
Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report
2022 Standout
Vonoprazan Triple and Dual Therapy for Helicobacter pylori Infection in the United States and Europe: Randomized Clinical Trial
2022 Standout
Works of Yu Takagi being referenced
Tailored eradication therapy based on fecalHelicobacter pyloriclarithromycin sensitivities
2008
A study of the relationship between Helicobacter pylori microbial susceptibility, 13C-urea breath test values.
2008
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Yu Takagi | 290 | 380 | 227 | 52 | 572 | |
| Seiichiro Fukuhara | 443 | 246 | 280 | 51 | 634 | |
| Duc Trong Quach | 470 | 259 | 228 | 62 | 569 | |
| Hiroko Nebiki | 303 | 149 | 141 | 50 | 497 | |
| Chang Beom Ryu | 390 | 372 | 194 | 54 | 590 | |
| Mika Yuki | 529 | 129 | 418 | 31 | 641 | |
| L Rutgeerts | 455 | 106 | 264 | 36 | 618 | |
| Hitomi Ichikawa | 428 | 210 | 235 | 42 | 489 | |
| G. Lepsien | 426 | 126 | 239 | 54 | 607 | |
| Dainius Jančiauskas | 416 | 237 | 157 | 30 | 529 | |
| Ji Hyung Nam | 339 | 297 | 129 | 50 | 603 |
All Works
Loading papers...